Therachon AG

Developing treatments for rare, genetic diseases

Therachon is a global biotechnology company, focused on developing treatments for rare, genetic diseases that currently have no available treatments. We are committed to the community, caregivers and advancing research to transform the lives of people with unmet medical needs. We are deeply committed to fostering a community that is rigorous about science and passionate about making a difference by translating the promise of our science into new treatments for patients.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

No milestones

No Jobs

No videos and documents

No Awards

Therachon AG

Developing treatments for rare, genetic diseases

Headquarter:
Basel

Foundation Date:
January 2016

Technology:

  • Biotech

Sectors:

  • Biotech